Artwork
iconShare
 
Manage episode 523448007 series 2084987
Content provided by Audioboom and Pharmaceutical Executive Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Pharmaceutical Executive Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In today’s Pharmaceutical Executive Daily, new analysis outlines how EMA support programs help lower drug market entry costs, early real-world data show sustained remissions with Carvykti in relapsed or refractory multiple myeloma, and Pfizer signs an exclusive collaboration with Yao Pharma to advance oral small-molecule GLP-1 agonists.
  continue reading

250 episodes